Treatment Cefotaxime for Injection, USP is indicated for the treatment of patients with serious infections caused by susceptible strains of the designated microorganisms in the diseases listed below.
From the U.S. FDA-approved label for Cefotaxime. Full label: DailyMed.
Treatment Cefotaxime for Injection, USP is indicated for the treatment of patients with serious infections caused by susceptible strains of the designated microorganisms in the diseases listed below. Lower respiratory tract infections, including pneumonia, caused by Streptococcus pneumoniae (formerly Diplococcus pneumoniae ), Streptococcus pyogenes* (Group A streptococci) and other streptococci (excluding enterococci, e.g., Enterococcus faecalis ), Staphylococcus aureus (penicillinase and non-penicillinase producing), Escherichia coli, Klebsiella species, Haemophilus influenzae (including ampicillin resistant strains), Haemophilus parainfluenzae, Proteus mirabilis, Serratia marcescens*, Enterobacter species, indole positive Proteus and Pseudomonas species (including P. aeruginosa ). Genitourinary infections. Urinary tract infections caused by Enterococcus species, Staphylococcus epidermidis, Staphylococcus aureus*, (penicillinase and non-penicillinase producing), Citrobacter species, Enterobacter species, Escherichia coli, Klebsiella species, Proteus mirabilis, Proteus vulgaris*, Providencia stuartii, Morganella morganii*, Providencia rettgeri*, Serratia marcescens and Pseudomonas species (including P.
From the U.S. FDA-approved label for Cefotaxime. Full label: DailyMed.
Adults Dosage and route of administration should be determined by susceptibility of the causative organisms, severity of the infection, and the condition of the patient (see table for dosage guideline). Cefotaxime may be administered IM or IV after reconstitution.
Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.
Cefotaxime is contraindicated in patients who have shown hypersensitivity to cefotaxime sodium, or the cephalosporin group of antibiotics.
Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.
BEFORE THERAPY WITH CEFOTAXIME IS INSTITUTED, CAREFUL INQUIRY SHOULD BE MADE TO DETERMINE WHETHER THE PATIENT HAS HAD PREVIOUS HYPERSENSITIVITY REACTIONS TO CEFOTAXIME SODIUM, CEPHALOSPORINS, PENICILLINS, OR OTHER DRUGS. THIS PRODUCT SHOULD BE GIVEN WITH CAUTION TO PATIENTS WITH TYPE I HYPERSENSITIVITY REACTIONS TO PENICILLIN. ANTIBIOTICS SHOULD BE ADMINISTERED WITH CAUTION TO ANY PATIENT WHO HAS DEMONSTRATED SOME FORM OF ALLERGY, PARTICULARLY TO DRUGS. IF AN ALLERGIC REACTION TO CEFOTAXIME OCCURS, DISCONTINUE TREATMENT WITH THE DRUG.
Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.
Clinical Trials Experience Cefotaxime is generally well tolerated. The most common adverse reactions have been local reactions following IM or IV injection. Other adverse reactions have been encountered infrequently. The most frequent adverse reactions (greater than 1%) are: Local (4.3%) - Injection site inflammation with IV administration. Pain, induration, and tenderness after IM injection.
Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.
294 products from 139 makers in the NepalDoc medicine catalog use this generic:
| Brand | Composition | Maker | Pack |
|---|---|---|---|
| Bactaxim 1gm Injection | Cefotaxime (1gm) | Claris Lifesciences Ltd | |
| Biotax 1gm Injection | Cefotaxime (1gm) | Biochem Pharmaceuticals Industries Limited. | |
| Biotax 250mg Injection | Cefotaxime (250mg) | Biochem Pharmaceuticals Industries Limited. | |
| Biotax 500mg Injection | Cefotaxime (500mg) | Biochem Pharmaceuticals Industries Limited. | |
| Biotex 1 1gm Injection | Cefotaxime (1gm) | Biochem Pharmaceuticals Industries Limited. | |
| Biotex 250 250mg Injection | Cefotaxime (250mg) | Biochem Pharmaceuticals Industries Limited. | |
| Biotex 500 500mg Injection | Cefotaxime (500mg) | Biochem Pharmaceuticals Industries Limited. | |
| Cefantral 1 1gm Injection | Cefotaxime (1gm) | Lupin Ltd. | |
| Cefantral 125 125mg Injection | Cefotaxime (125mg) | Lupin Ltd. | |
| Cefantral 250 250mg Injection | Cefotaxime (250mg) | Lupin Ltd. | |
| Cefantral 500 500mg Injection | Cefotaxime (500mg) | Lupin Ltd. | |
| Cefot 1 1gm Injection | Cefotaxime (1gm) | National Healthcare Pvt. Ltd. | |
| Cefot 250 250mg Injection | Cefotaxime (250mg) | National Healthcare Pvt. Ltd. | |
| Cefot 500 500mg Injection | Cefotaxime (500mg) | National Healthcare Pvt. Ltd. | |
| Cefotaxime MJ 1gm Injection | Cefotaxime (1gm) | Macleods Pharmaceuticals Pvt. Ltd. | |
| Ominax 1 1gm Injection | Cefotaxime (1gm) | Mapra Laboratories Pvt Ltd. | |
| Ominax 125 125mg Injection | Cefotaxime (125mg) | Mapra Laboratories Pvt Ltd. | |
| Ominax 250 250mg Injection | Cefotaxime (250mg) | Mapra Laboratories Pvt Ltd. | |
| Ominax 500 500mg Injection | Cefotaxime (500mg) | Mapra Laboratories Pvt Ltd. | |
| Omnicef 1 1gm Injection | Cefotaxime (1gm) | Aristo Pharmaceuticals Ltd. | |
| Omnicef 125 125mg Injection | Cefotaxime (125mg) | Aristo Pharmaceuticals Ltd. | |
| Omnicef 250 250mg Injection | Cefotaxime (250mg) | Aristo Pharmaceuticals Ltd. | |
| Omnicef 500 500mg Injection | Cefotaxime (500mg) | Aristo Pharmaceuticals Ltd. | |
| Sitoxime 1 1gm Injection | Cefotaxime (1gm) | Shiv Pharmaceutical Laboratories | |
| Sitoxime 250 250mg Injection | Cefotaxime (250mg) | Shiv Pharmaceutical Laboratories | |
| Sitoxime 500 500mg Injection | Cefotaxime (500mg) | Shiv Pharmaceutical Laboratories | |
| Taxicon 1gm Injection | Cefotaxime (1gm) | Concept Pharmaceuticals Ltd. | |
| Taxim 1 1gm Injection | Cefotaxime (1gm) | Alkem Laboratories Ltd. | |
| Taxim 125 125mg Injection | Cefotaxime (125mg) | Alkem Laboratories Ltd. | |
| Taxim 250 250mg Injection | Cefotaxime (250mg) | Alkem Laboratories Ltd. |
Showing 30 of 294 catalog products. Search the full catalog in the app.
Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.
Stored at 20º to 25°C (68º to 77°F). Storage conditions and should be protected from elevated temperatures and excessive light.
Storage information from the U.S. FDA-approved label.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. NLEM listing does not guarantee that a medicine is in stock at any pharmacy.